Gareth Parry mostly deals with Surgery, Internal medicine, Anesthesia, Intensive care and Nerve conduction velocity. His work carried out in the field of Surgery brings together such families of science as Clinical trial, Physical medicine and rehabilitation, Neurology, Pulmonary function testing and Heart disease. Within one scientific family, Gareth Parry focuses on topics pertaining to Gastroenterology under Internal medicine, and may sometimes address concerns connected to Organ transplantation.
His Anesthesia study incorporates themes from Placebo, Vital capacity and Amyotrophic lateral sclerosis. His studies deal with areas such as Anesthesiology, Emergency medical services, Emergency medicine and Risk assessment as well as Intensive care. The study incorporates disciplines such as Somatosensory evoked potential, Electromyography, Polyneuropathy and Polyradiculoneuropathy in addition to Nerve conduction velocity.
His primary scientific interests are in Internal medicine, Surgery, Transplantation, Cardiology and Pediatrics. His research integrates issues of Gastroenterology, Endocrinology and Immunology in his study of Internal medicine. His Surgery study frequently intersects with other fields, such as Anesthesia.
Specifically, his work in Transplantation is concerned with the study of Heart transplantation. His Ventricular assist device and Heart failure study are his primary interests in Cardiology. His Pediatrics study frequently draws parallels with other fields, such as Intensive care.
His primary areas of investigation include Internal medicine, Health care, Patient safety, Cardiology and Quality management. Internal medicine is often connected to Gastroenterology in his work. His Health care research is multidisciplinary, incorporating elements of Cross-sectional study, Extension, Family medicine and Environmental health.
The various areas that Gareth Parry examines in his Patient safety study include Medical emergency, Emergency medicine, Qualitative research, Medication administration and Harm. His work on Ventricular assist device, Heart disease and Right heart failure is typically connected to Bivalirudin as part of general Cardiology study, connecting several disciplines of science. Gareth Parry combines subjects such as Physical therapy, Surgical site infection, Evidence-based medicine and Process management with his study of Quality management.
Gareth Parry spends much of his time researching Patient safety, Context, Adverse effect, Process management and Complex adaptive system. His Patient safety research is multidisciplinary, relying on both Thematic analysis, Harm and Medical emergency. His research in Harm intersects with topics in Intervention, Secondary care, Primary care and Near miss.
His Medical emergency study combines topics in areas such as Methadone, Health services research and Community-based care. His Adverse effect study integrates concerns from other disciplines, such as Myasthenia gravis, Edrophonium, Emergency medicine and Pediatric patient. He usually deals with Process management and limits it to topics linked to Quality management and Health care.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Connexin 26 mutations in hereditary non-syndromic sensorineural deafness
Kelsell Dp;Dunlop J;Stevens Hp;Lench Nj.
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo;Anne Dipchand;Randall Starling;Allen Anderson.
Journal of Heart and Lung Transplantation (2010)
Temporal Trends in Rates of Patient Harm Resulting from Medical Care
Christopher P. Landrigan;Gareth J. Parry;Catherine B. Bones;Andrew D. Hackbarth.
The New England Journal of Medicine (2010)
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
R Soiffer;T Lynch;M Mihm;K Jung.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Quantitative sensory testing: Report of the therapeutics and technology assessment subcommittee of the American academy of neurology
M. E. Shy;E. M. Frohman;Y. T. So;J. C. Arezzo.
Systematic review and evaluation of physiological track and trigger warning systems for identifying at-risk patients on the ward
Haiyan Gao;Ann McDonnell;David A. Harrison;Tracey Moore.
Intensive Care Medicine (2007)
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
M Cohen;P C Adams;G Parry;J Xiong.
CRIB II: an update of the clinical risk index for babies score
Gareth Parry;Janet Tucker;William Tarnow-Mordi.
The Lancet (2003)
A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis
Robert G. Miller;Jack H. Petajan;Wilson W. Bryan;Carmel Armon.
Annals of Neurology (1996)
Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation
E. Kaltenthaler;John Brazier;E. De Nigris;I. Tumur.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: